Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com

Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration

Flagstaff, Ariz. and New York. (November 18, 2015) — W. L. Gore & Associates, Inc. (Gore) today announced the nominees and opening of voting for the 2016 Pioneers in Performance Awards for North America. Today’s announcement came at the 2015 VEITHsymposium® in New York. Each year, a distinguished group of physicians are honored with the Pioneers in Performance Awards sponsored by Gore. This year’s nominees can be viewed by visiting http://pioneersinperformance.com/na. These physicians have been nominated by their peers for their unrelenting dedication to advancing vascular and endovascular therapy and minimally invasive treatment options for patients worldwide, including aortic and lower-limb bypass and dialysis access surgery.

The academy of past recipients of the Pioneers in Performance selected the nominees; the 2016 honorees will be chosen by ballot. Voting is now open to the medical community and is available via the online site and at Gore pavilions at major clinical conferences throughout the year. Voting closes in October 2016 and ballots are kept confidential. Final winners will be honored during a special reception in November at the 2016 VEITHsymposium.

The academy of past recipients selected nominees across four major categories that reflect a strong and ongoing commitment to improving clinical and patient performance through collaboration. Nominees have demonstrated collaboration as it relates to improving patient and clinical performance: a commitment to ongoing learning, dedication to sharing knowledge with peers and patients, dedication to creating consensus within the medical community, and a dedication to analysis of outcomes.

“The Pioneers in Performance program brings together members of the vascular community to honor the inspiring work of their peers across Europe, North America, and Latin America and this year is no exception as we congratulate the newest nominees,” said Ryan Takeuchi, Gore Aortic Business Leader. “All of the nominees have shown an unrelenting dedication when it comes to driving medical innovation and improving clinical and patient outcomes, thus we look forward to finding out who the vascular community will honor.”

About VEITHsymposium

Now in its 42nd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies, and new techniques. To register to attend VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at tel: 631.979.3780.

ABOUT US

At Gore, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the US “100 Best Companies to Work For” lists since the rankings debuted in 1984.